| A placebo controlled treatment trial of sertraline and interpersonal psychotherapy for postpartum depression.
|
|
2019
|
| The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio: A Retrospective Cohort Study.
|
|
2018
|
| Neonatal outcomes in pregnant women with untreated and treated panic disorder.
|
|
2018
|
| Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
|
|
2019
|
| Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
|
|
|
| The use of antidepressant drugs in pregnant women with epilepsy: A study from the Australian Pregnancy Register.
|
|
2018
|
| Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine.
|
|
2018
|
| Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
|
|
|
| Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
|
|
2018
|
| Comparison of two different treatments in depressed pregnant women: fetal growth characteristics and neonatal outcomes.
|
|
2018
|
| Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders.
|
|
-- Not Found --
|
| Aripiprazole and pregnancy: A retrospective, multicentre study.
|
|
2018
|
| Antidepressants and recurrence of depression in the postpartum period.
|
|
2018
|
| Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale.
|
|
2018
|
| Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.
|
|
2018
|
| Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhood.
|
|
2018
|
| Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy.
|
|
-- Not Found --
|
| Antidepressant Use in Late Gestation and Breastfeeding Rates at Discharge from Hospital.
|
|
2017
|
| Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study.
|
|
|
| Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
|
|
2017
|
| Use of atypical antipsychotics in pregnancy and maternal gestational diabetes.
|
|
2017
|
| Antidepressants during pregnancy and autism in offspring: population based cohort study.
|
|
2017
|
| Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring.
|
|
|
| Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study.
|
|
2017
|
| Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children.
|
|
2017
|
| Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
|
|
2017
|
| Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation.
|
|
2017
|
| Lithium Use in Pregnancy and the Risk of Cardiac Malformations.
|
|
2017
|
| Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
|
|
2017
|
| Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
|
|
2017
|
| Autism risk following antidepressant medication during pregnancy.
|
|
2017
|
| Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study.
|
|
2017
|
| Pregnancy and postpartum antidepressant use moderates the effects of sleep on depression.
|
|
2017
|
| The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness.
|
|
2017
|
| Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
|
|
2017
|
| Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation.
|
|
2016
|
| Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
|
|
2016
|
| Prenatal exposure to antidepressants and risk of epilepsy in childhood.
|
|
2016
|
| Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.
|
|
2016
|
| Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
|
|
2013
|
| Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.
|
|
2017
|
| Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort.
|
|
2016
|
| Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy.
|
|
2016
|
| Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
|
|
2016
|
| Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions.
|
|
2016
|
| Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.
|
|
2016
|
| Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.
|
|
2016
|
| Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome.
|
|
2016
|
| The effect of antidepressants on fertility.
|
|
2016
|
| Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.
|
|
2016
|
| The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
|
|
2016
|
| Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.
|
|
2015
|
| Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.
|
|
2015
|
| Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
|
|
2015
|
| Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
|
|
2015
|
| Antidepressant medication use, depression, and the risk of preeclampsia.
|
|
2015
|
| Antidepressant use during pregnancy and asthma in the offspring.
|
|
2015
|
| No association between prenatal exposure to psychotropics and intelligence at age five.
|
|
2015
|
| Sertraline use during pregnancy and the risk of major malformations.
|
|
2015
|
| Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial.
|
|
2015
|
| Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases.
|
|
2015
|
| Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
|
|
2014
|
| First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.
|
|
2014
|
| Antidepressant use in pregnancy and the risk of cardiac defects.
|
|
2014
|
| Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.
|
|
2014
|
| Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
|
|
2014
|
| Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants.
|
|
2014
|
| Effects of maternal psychotropic drug dosage on birth outcomes.
|
|
2014
|
| Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.
|
|
2014
|
| Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
|
|
2013
|
| Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
|
|
2013
|
| A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression.
|
|
2014
|
| Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.
|
|
2014
|
| Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.
|
|
2013
|
| Antidepressant use and risk for preeclampsia.
|
|
2013
|
| Does fetal exposure to SSRIs or maternal depression impact infant growth?
|
|
2013
|
| Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
|
|
2012
|
| Prenatal antidepressant exposure and behavioral problems in early childhood--a cohort study.
|
|
2013
|
| Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.
|
|
2012
|
| Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study.
|
|
2012
|
| Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
|
|
2012
|
| Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
|
|
2012
|
| Prenatal antipsychotic exposure and neuromotor performance during infancy.
|
|
2012
|
| Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?
|
|
2012
|
| Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics.
|
|
2012
|
| The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study.
|
|
2012
|
| Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
|
|
2012
|
| Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
|
|
2011
|
| A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure.
|
|
2011
|
| Association between antidepressant use during pregnancy and infants born small for gestational age.
|
|
2010
|
| Use of antidepressants during pregnancy and the risk of spontaneous abortion.
|
|
2010
|
| Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.
|
|
2009
|
| Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?
|
|
2010
|
| Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
|
|
|
| Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.
|
|
2009
|
| Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
|
|
2009
|
| Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
|
|
2009
|
| Postpartum depression: a randomized trial of sertraline versus nortriptyline.
|
|
2006
|
| Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome.
|
|
2008
|
| Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study.
|
|
|
| Lamotrigine in bipolar disorder: efficacy during pregnancy.
|
|
2008
|
| Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.
|
|
2008
|
| Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
|
|
2007
|
| Birth outcomes following prenatal exposure to antidepressants.
|
|
2007
|
| Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
|
|
2007
|
| Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.
|
|
|
| Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
|
|
2007
|
| First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
|
|
2007
|
| Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
|
|
2006
|
| Patient choice of treatment for postpartum depression: a pilot study.
|
|
2006
|
| Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
|
|
2006
|
| Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder.
|
|
2006
|
| Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.
|
|
2006
|
| Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.
|
|
2006
|
| Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.
|
|
2005
|
| Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
|
|
|
| Prevention of postpartum episodes in women with bipolar disorder.
|
|
2004
|
| The impact of depression and fluoxetine treatment on obstetrical outcome.
|
|
2004
|
| Neonate characteristics after maternal use of antidepressants in late pregnancy.
|
|
2004
|
| Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
|
|
2004
|
| Frequency of infant adverse events that are associated with citalopram use during breast-feeding.
|
|
2004
|
| Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
|
|
2003
|
| Outcomes of prenatal antidepressant exposure.
|
|
2002
|
| Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
|
|
2002
|
| Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
|
|
2001
|
| Outcome of children exposed in utero to fluoxetine: a critical review.
|
|
1998
|
| Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
|
|
1993
|
| A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression.
|
|
1997
|
| Neurodevelopment of children exposed in utero to antidepressant drugs.
|
|
1997
|
| Association of maternal lithium exposure and premature delivery.
|
|
-- Not Found --
|
| Lithium and pregnancy. A cohort study on manic-depressive women.
|
|
1983
|
| Hydroxyzine for controlling postpartum anxiety: a double-blind study.
|
|
1967
|
| One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder.
|
|
-- Not Found --
|
| Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
|
|
2018
|
| Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.
|
|
2013
|
| Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study.
|
|
|
| Birth weight and use of olanzapine in pregnancy: a prospective comparative study.
|
|
2010
|
| Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records.
|
|
2016
|
| Zolpidem (Ambien) in pregnancy: placental passage and outcome.
|
|
2009
|
| Duration of antidepressant use during pregnancy and risk of major congenital malformations.
|
|
2008
|
| Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes.
|
|
2019
|
| Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
|
|
2016
|
| Risk of adverse perinatal outcomes among women with pharmacologically treated and untreated depression during pregnancy: A retrospective cohort study.
|
|
2019
|
| Risk of Congenital Heart Disease in Newborns with Prenatal Exposure to Anti-depressant Medications.
|
|
2019
|
| The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: A multicentre study.
|
|
2020
|
| Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.
|
|
2019
|
| Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage.
|
|
2020
|
| Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study.
|
|
2019
|
| In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners.
|
|
2020
|
| Obstetric complications in bipolar disorder: Psychiatric factors and the risk of caesarean section.
|
|
2020
|
| Pregnancy hypertension and its associations with pre-pregnancy depression, anxiety, antidepressants, and anxiolytics.
|
|
2019
|
| Antidepressant Use around Conception, Prepregnancy Depression, and Risk of Ectopic Pregnancy.
|
|
2020
|
| Benzodiazepine use before conception and risk of ectopic pregnancy.
|
|
2020
|
| Antidepressant continuation in pregnancy and risk of gestational diabetes.
|
|
2019
|
| Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data.
|
|
2019
|
| The mother, the infant and the mother-infant relationship: What is the impact of antidepressant medication in pregnancy.
|
|
2020
|
| Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy.
|
|
2019
|
| Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes.
|
|
2019
|
| The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study.
|
|
2019
|
| Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
|
|
2020
|
| Analysis of Perinatal Women Attending a Mother and Baby Unit Taking Sodium Valproate or Lithium with a Diagnosis of Bipolar Affective Disorder.
|
|
2020
|
| The effect of maternal antidepressants on third trimester uteroplacental hemodynamics and the neonatal abstinence syndrome: a retrospective cohort study.
|
|
2019
|
| Postpartum Bleeding in Pregnant Women Receiving SSRIs/SNRIs: New Insights From a Descriptive Observational Study and an Analysis of Data from the FAERS Database.
|
|
2019
|
| Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics.
|
|
2019
|
| Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion.
|
|
2019
|
| Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
|
|
2020
|
| Bupropion in pregnancy and the prevalence of congenital malformations.
|
|
2007
|
| Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder
|
|
2019
|